Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A Human Mass Balance and Metabolism Study of [14C]-Ubrogepant in Healthy Male Adults.
Journal: Clinical pharmacology in drug development
Published: August 26, 2025
In Vitro Assessment of Transporter Mediated Perpetrator DDIs for Several Hepatitis C Virus Direct-Acting Antiviral Drugs and Prediction of DDIs with Statins Using Static Models.
Journal: The AAPS journal
Published: August 09, 2021
Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters.
Journal: Viruses
Published: May 25, 2021
In Vitro Evaluation of the Drug Interaction Potential of Doravirine.
Journal: Antimicrobial agents and chemotherapy
Published: November 28, 2018
Role of transporters in the disposition of a novel β-lactamase inhibitor: relebactam (MK-7655).
Journal: The Journal of antimicrobial chemotherapy
Published: October 11, 2018
Structure-Activity Relationship of Novel and Selective Biaryl-Chroman GPR40 AgoPAMs.
Journal: ACS medicinal chemistry letters
Published: March 29, 2018
Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin.
Journal: British journal of clinical pharmacology
Published: January 06, 2014
Raltegravir has a low propensity to cause clinical drug interactions through inhibition of major drug transporters: an in vitro evaluation.
Journal: Antimicrobial agents and chemotherapy
Published: December 04, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026